Menu

Epigenetics of Obesity

Differential expression of a chromatin-interacting protein is linked to weight variation in mice and humans, researchers show.

Jan 29, 2016
Catherine Offord

WIKIMEDIA, SCHUMINWEBLast year, the World Health Organization estimated that more than 600 million people in the world are obese. Although studies have revealed genetic contributors to weight, the hereditary component of obesity is not well understood. Now, the results of a study published yesterday (January 28) in Cell have suggested that a person’s predisposition to obesity is at least partially determined by epigenetic regulation.

“We show that you can have a strong phenotype [obesity] with absolutely no genetic underpinnings,” study coauthor J. Andrew Pospisilik of the Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany, told Science.

Previous work had shown that genetically identical mice with only one copy of Trim28—a gene that encodes a chromatin-interacting regulatory protein—showed considerable variation in weight. Generating their own populations of “identical” mutant mice, the researchers discovered that this variation was not normally distributed, but associated with two distinct groups: lean animals and obese ones.

When the team probed the mutants’ gene-expression profiles, it found that mice in the obese group showed reduced expression of an interacting network of imprinted genes—those that are expressed by either the maternally or paternally inherited copy. The results suggest that the Trim28 protein forms part of an epigenetic switch, the authors wrote in their paper.

“Once the switch is triggered, it is a lifelong, epigenetically driven decision that ends in a stable, either a lean or obese phenotype,” Pospisilik said in a press release. “The effect is akin to a light switch—on or off, lean or obese.”

Turning to humans, the researchers found that Trim28 expression was unusually low among obese children. What’s more, publicly available datasets from genetically identical twins with different weight profiles suggested a similar relationship between gene expression and body mass index, supporting an epigenetic component to obesity.

Paul Franks of the Lund University Diabetes Center in Malmö, Sweden, who was not involved in the work, told Science the researchers now must identify the regulators of this network switch. “The big question now is, ‘What is the trigger?’” he said. “If you could determine what that was, you’d have the basis for intervention.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.